199 related articles for article (PubMed ID: 11234138)
21. Carvedilol and atenolol once daily in the treatment of hypertension.
Luurila OJ; Härkönen R; Hilden M; Icen R; Kohvakka A; Linna M; Sillanpää J; Vänskä O; Lukkala K
J Hypertens Suppl; 1989 Dec; 7(6):S264-5. PubMed ID: 2576666
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide.
van der Does R; Widmann L; Uberbacher HJ; Hörrmann M; Machwirth M; Stienen U
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S147-52. PubMed ID: 1974506
[TBL] [Abstract][Full Text] [Related]
23. Treatment of chronic stable angina with carvedilol in comparison with nifedipine s.r.
van der Does R; Eberhardt R; Derr I; Ehmer B; Rudorf J; Uberbacher HJ
Eur Heart J; 1991 Jan; 12(1):60-4. PubMed ID: 2009895
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the safety and efficacy of bisoprolol versus atenolol in stable exercise-induced angina pectoris: a Multicenter International Randomized Study of Angina Pectoris (MIRSA).
de Muinck ED; Buchner-Moell D; van de Ven LL; Lie KI
J Cardiovasc Pharmacol; 1992 Jun; 19(6):870-5. PubMed ID: 1376806
[TBL] [Abstract][Full Text] [Related]
25. Effects of bevantolol and atenolol on symptoms, exercise tolerance and metabolic risk factors in angina pectoris.
Salonen JT; Taskinen E; Salonen R; Seppänen K; Venäläinen J; Rauramaa R
Am J Cardiol; 1986 Nov; 58(12):35E-40E. PubMed ID: 2878600
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of carvedilol in exercise-induced myocardial ischemia.
Kaski JC; Rodriguez-Plaza L; Brown J; Maseri A
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S137-40. PubMed ID: 2454360
[TBL] [Abstract][Full Text] [Related]
27. Celiprolol and atenolol in angina--effects on left ventricular function.
Dargie H; McLenachan JM; Wilson JT
J Int Med Res; 1988; 16 Suppl 1():47A-51A. PubMed ID: 2906017
[TBL] [Abstract][Full Text] [Related]
28. Multiple action compounds in angina pectoris.
Kelly DT; Freedman SB
Z Kardiol; 1989; 78 Suppl 3():16-20. PubMed ID: 2573212
[TBL] [Abstract][Full Text] [Related]
29. Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol.
McLenachan JM; Wilson JT; Dargie HJ
Br Heart J; 1988 Jun; 59(6):685-9. PubMed ID: 2899439
[TBL] [Abstract][Full Text] [Related]
30. Effects of carvedilol in patients with impaired left ventricular function due to ischaemic heart disease.
Lahiri A; Rodrigues EA; DasGupta P; Jain D; van der Does R; Raftery EB
Z Kardiol; 1989; 78 Suppl 3():21-7. PubMed ID: 2573213
[TBL] [Abstract][Full Text] [Related]
31. [A randomized comparison of carvedilol and metoprolol in patients with chronic heart failure. The Carvedilol Or Metoprolol European Trial (COMET) ].
Torp-Pedersen CT;
Ugeskr Laeger; 2004 Aug; 166(32):2671-4. PubMed ID: 15347171
[No Abstract] [Full Text] [Related]
32. Comparison between a sustained administration of carvedilol versus atenolol to reduce restenosis after coronary stenting.
Cha KS; Kim MH; Kim JW; Kim DI; Kim HJ; Kim DS; Kim JS
Am Heart J; 2004 Feb; 147(2):E7. PubMed ID: 14760341
[TBL] [Abstract][Full Text] [Related]
33. The COMET trial.
Bristow MR; Adams KF; Bauman JL; Feldman AM; Giles TD; Goldstein S; Mann DL; Talbert RL
Congest Heart Fail; 2005; 11(1):39-47. PubMed ID: 15722669
[No Abstract] [Full Text] [Related]
34. Bopindolol and atenolol in patients with stable angina pectoris. Double-blind randomized comparative trial.
Hertzeanu H; Shemesh J; Loidl AF; Kellermann JJ
Cardiology; 1989; 76(4):312-8. PubMed ID: 2572323
[TBL] [Abstract][Full Text] [Related]
35. Angina, ischemia, and effort tolerance with vasodilating beta-blockers.
Dargie HJ; Grant S; McLenachan J
Am Heart J; 1991 Mar; 121(3 Pt 2):1017-20. PubMed ID: 1671726
[TBL] [Abstract][Full Text] [Related]
36. A comparison of carvedilol with atenolol in the treatment of mild-to-moderate essential hypertension. INT-CAR-07 (U.K.) Study Group.
Young PH
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S82-5. PubMed ID: 1378155
[TBL] [Abstract][Full Text] [Related]
37. Vasodilating beta-blockers in heart failure.
Raftery EB
Eur Heart J; 1995 Jul; 16 Suppl F():32-7. PubMed ID: 8521882
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.
Ollivier JP; Durier P; Bussiere JL; Gayet JL
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S164-6. PubMed ID: 1974509
[TBL] [Abstract][Full Text] [Related]
39. Effect of atenolol on treadmill performance in patients with angina pectoris.
Kritzer G; Warr TA; Strong ML; Froelicher VF
Clin Pharm; 1983; 2(3):236-42. PubMed ID: 6349909
[TBL] [Abstract][Full Text] [Related]
40. [Effects of the K(+) channel blocker tedisamil on hemodynamics, myocardial ischemia and neurohumoral systems in patients with stable angina pectoris. A comparison with the beta blocker atenolol].
Mitrovic V; Miskovic A; Straub M; Beckmann K; Thormann J; Pitschner H
Z Kardiol; 1999 Oct; 88(10):838-49. PubMed ID: 10552188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
